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Group B streptococcus (GBS) is an important cause of early- and late-onset sepsis in the newborn. Preterm
infants have markedly increased susceptibility and worse outcomes, but their immunological responses to GBS
are poorly deﬁned. We compared mononuclear cell and whole-blood cytokine responses to heat-killed GBS
(HKGBS) of preterm infants (gestational age [GA], 26 to 33 weeks), term infants, and healthy adults. We
investigated the kinetics and cell source of induced cytokines and quantiﬁed HKGBS phagocytosis. HKGBS-
induced tumor necrosis factor (TNF) and interleukin 6 (IL-6) secretion was signiﬁcantly impaired in preterm
infants compared to that in term infants and adults. These cytokines were predominantly monocytic in origin,
and production was intrinsically linked to HKGBS phagocytosis. Very preterm infants (GA, <30 weeks) had
fewer cytokine-producing monocytes, but nonopsonic phagocytosis ability was comparable to that for term
infants and adults. Exogenous complement supplementation increased phagocytosis in all groups, as well as
the proportion of preterm monocytes producing IL-6, but for very preterm infants, responses were still
deﬁcient. Similar defective preterm monocyte responses were observed in fresh whole cord blood stimulated
with live GBS. Lymphocyte-associated cytokines were signiﬁcantly deﬁcient for both preterm and term infants
compared to levels for adults. These ﬁndings indicate that a subset of preterm monocytes do not respond to
GBS, a defect compounded by generalized weaker lymphocyte responses in newborns. Together these deﬁcient
responses may increase the susceptibility of preterm infants to GBS infection.
Streptococcus agalactiae (group B streptococcus [GBS]) is
the leading infectious cause of death in the newborn (17),
causing both early- and late-onset neonatal sepsis (EOS and
LOS), characterized by septicemia, shock, and meningitis (16,
18, 31). The proportion of infants surviving extreme prematu-
rity is increasing (11), and as a result preterm delivery is now
the leading cause of neonatal morbidity and mortality. Preterm
infants are exquisitely susceptible to both EOS and LOS; they
suffer approximately a quarter of invasive GBS EOS cases and
half of GBS LOS cases, with a 8-fold-greater mortality for
EOS and 3-fold for LOS compared to term infants (29). While
a proportion of the increased susceptibility to infection in pre-
term infants relates to the absence of passively acquired ma-
ternal IgG antibody, deﬁciencies in the early immune response
to bacterial pathogens likely play a critical role (23). Several
studies have addressed neonatal adaptive and humoral im-
mune responses, such as complement activation and antibody
production, but there has been little focus on innate immunity
to bacterial pathogens and its relation to adaptive responses in
this population (23, 39).
Innate immunity provides the ﬁrst line of defense against
bacterial infection and is therefore particularly important in
the neonatal period (9). Additionally, the innate immune sys-
tem, through activation of speciﬁc pattern recognition recep-
tors engaging pathogen-associated molecular patterns, drives
inﬂammation and in turn initiates and shapes the adaptive
immune response (28). The relative inability of the neonatal
immune system to mount an effective T helper 1 (Th1) re-
sponse to allergic and polyclonal stimuli is well documented
(12, 21, 41) and is suggested to represent an evolutionary
adaptation that protects the placenta from the proinﬂamma-
tory cytokine tumor necrosis factor alpha (TNF-) and the Th1
cytokine gamma interferon (IFN-) (43). However, most stud-
ies relate to the neonatal Th2 bias in response to allergic and
polyclonal stimuli (30), with fewer data on lymphocyte-driven
cytokine responses to bacterial stimuli. There is little informa-
tion on innate and lymphocyte cytokine responses to GBS in
preterm infants.
We therefore compared expression of monocyte- and lym-
phocyte-associated cytokines in response to heat-killed GBS
(HKGBS) in preterm, term, and adult mononuclear cells and
whole blood. We also examined the kinetics and cellular basis
of these responses and examined whole-blood responses to live
bacterial challenge.
MATERIALS AND METHODS
Study population and sample collection. The study was approved by the King
Edward Memorial Hospital ethics committee, and written informed consent was
obtained from parents/guardians. Cord blood from preterm infants (gestational
age [GA], 26 to 33 weeks) and term infants (GA, 37 weeks) was collected
within a few minutes of delivery from mothers without histologic evidence of
chorioamnionitis (32). Manual full-blood counts done at the time of collection
showed similar total white cell and monocyte counts for all newborn groups (data
not shown). Cord blood mononuclear cells (CBMC) were isolated by Lym-
phoprep gradient centrifugation (Nycomed Pharmacia, Norway) before cryo-
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1588preservation as previously reported (42). Peripheral blood mononuclear cell
(PBMC) samples were collected from healthy nonatopic adults, as previously
described (38). Whole fresh cord/venous blood from an additional 6 extreme-
preterm infants (GA, 30 weeks), 8 term infants (GA, 37 weeks), and 9
healthy adults was collected into heparinized tubes prior to use.
Preparation of live and heat-killed GBS. A clinical isolate of GBS serotype 1a
(strain M141) was kindly provided by Lyn Gilbert (Institute of Clinical Pathology
and Medical Research, Sydney, Australia). Mid-log-phase cultures (optical den-
sity at 600 nm [OD600]  0.8) grown in brain heart infusion broth (Pathwest
Laboratories, Perth, Australia) were used for the experiments with live GBS.
Bacteria were washed twice with phosphate-buffered saline (PBS) (Invitrogen,
Australia) by centrifugation at 250  g for 10 min and resuspended in fresh PBS
at a density of 2.5  10
9 CFU/ml after direct counting using a Helber counting
chamber. For generation of the HKGBS stock, M141 was grown to a ﬁnal density
of 2  10
10 CFU/ml in Todd-Hewitt broth, heat killed in a water bath at 60°C for
45 min, and harvested by centrifugation. HKGBS was washed in PBS, aliquoted
at 2.5  10
9 CFU/ml, and stored at 80°C. Bacterial killing was conﬁrmed by
lack of growth on agar at 48 h. HKGBS stock was determined to be free of
lipopolysaccharide (LPS) and mycoplasma contamination by HEK-TLR4 bioas-
say and validated PCR (data not shown).
Stimulation of CBMC/PBMC. Mononuclear cells (MNC) were thawed, cen-
trifuged, and resuspended in AIM-V (Gibco, Life Technology, Paisley, Scotland)
supplemented with 2-mercaptoethanol (2-ME) (Sigma, Castle Hill, Australia) at
2  10
6/ml. Cells were plated out in duplicate on 96 round-bottom well plates in
250-l aliquots and stimulated with either HKGBS (1  10
8 CFU/ml) or phy-
tohemagglutinin (PHA) (1 g/ml) for 48 h at 37°C (with 5% CO2). The optimal
dose and time chosen for HKGBS were based on optimization experiments using
both term cord blood mononuclear cells and adult peripheral blood mononu-
clear cells. It should be noted that by “optimal” we are referring to maximal
cytokine release for all cytokines measured, without evidence of cytotoxicity.
Higher doses were tested but showed signs of cytotoxicity and even reduced
cytokine production.
Stimulation of fresh cord and venous blood. Fresh heparinized cord or adult
venous blood was mixed 1:1 with RPMI medium supplemented with 2-ME and
5% (vol/vol) heat-inactivated fetal calf serum (FCS), and 100-l aliquots were
placed in a 96-well polypropylene tissue culture plate (Corning Inc., Australia).
Live GBS were added at various doses (10
5 to 10
7 CFU/ml) for 18 h; then, plates
were centrifuged at 250  g for 4 min to pellet red blood cells, and supernatants
were harvested and stored at 80°C.
Cytokine assays. Cytokines (IFN-, interleukin 13 [IL-13], IL-6, IL-10, and
TNF-) from MNC cultures were measured by time-resolved ﬂuorometry as
previously described (33). Cytokine levels in supernatants of whole-blood cul-
tures were determined using the BioPlex200 system (Bio-Rad Laboratories) in
accordance with the manufacturer’s instructions.
pHrodo labeling of HKGBS. For phagocytosis and intracellular cytokine ex-
periments, HKGBS were labeled with the pH-sensitive ﬂuorescent dye pHrodo
(Invitrogen) according to the manufacturer’s instructions. Before use, pHrodo-
labeled HKGBS were thoroughly dispersed by 30 s of rapid vortexing and 3 min
in an ultrasonic water bath.
Phagocytosis assay. C/PBMC (1.25  10
5/125 l/well in a 96-well polypropyl-
ene plate) were cultured for1ha t37°C in the presence of pHrodo-labeled
HKGBS (100 bacteria/cell) with or without 10% (vol/vol) rabbit complement
(RbC) (Sigma) and then transferred to a 3-ml ﬂuorescence-activated cell sorter
(FACS) tube, and nonadherent bacteria were removed by washing twice with 2
ml of ice-cold PBS (250  g, 5 min) before ﬁxation in 2% (vol/vol) formalin
solution (in PBS). Alternatively, 25 l of fresh whole blood was mixed with 100
l of RPMI plus 5% FCS and 2-ME and incubated at 37°C for 15 min with a
previously optimized dose of pHrodo-labeled HKGBS (5  10
7/ml). Diluted
blood was ﬁxed, and red cells were lysed using BD FACS lysis solution (BD
Biosciences) according to the manufacturer’s instruction. Cells were washed
twice with PBS and stored in 1 BD stabilizing ﬁxative solution (BD Biosci-
ences).
Intracellular cytokine (ICC) staining. CBMC/PBMC were cultured with
pHrodo-labeled HKGBS (as described previously) for 1 h. Fresh blood was
cultured as described previously but for 30 min with various doses of live,
unlabeled GBS. These time points were chosen from previous phagocytosis
kinetic optimization experiments, which demonstrated that the maximum pro-
portion of monocytes ingesting either HKGBS or live GBS occurred at 60 min or
30 min, respectively (data not shown). Cells were incubated for a further4ha t
37°C in the presence of 6 g/ml of brefeldin A (eBioscience, San Diego, CA) and
transferred to a round-bottom polystyrene 96-well plate, washed twice with
ice-cold PBS (250  g, 5 min), and immediately ﬁxed using BD FACS lysing
solution. Cells were permeabilized using 1 BD Perm2 permeabilization buffer
for 10 min, washed with PBS, and incubated with ﬂuorescein isothiocyanate
(FITC)- or allophycocyanin (APC)-labeled antibodies against TNF- or IL-6
(eBioscience, San Diego, CA) or appropriate isotype controls for 30 min at 4°C
in the dark before two ﬁnal washes and ﬁxation in 1 BD stabilizing ﬁxative
solution.
For the kinetic studies, PBMCs were stimulated for 0 to 48 h before addition
of brefeldin A (6 g/ml) for the ﬁnal 4 h. Cells were harvested at each time point,
counterstained with phycoerythrin (PE)-Cy5.5-labeled anti-CD3 and APC-la-
beled anti-HLA-DR antibodies (eBioscience), and identiﬁed based on granular-
ity (side scatter) and CD3/HLA-DR expression (monocytes, medium side scat-
ter, CD3
, HLA-DR
; T cells, low side scatter, CD3
, HLA-DR
/; B cells, low
side scatter, CD3
, HLA-DR
. Fixed and permeabilized cells were incubated
with FITC-labeled anti-IL-6 and PE-labeled anti-IL-10 antibodies or FITC-
labeled anti-TNF- antibodies before washing and ﬁnal ﬁxation, as above.
For all assays, 2,000 monocytes, identiﬁed by their forward- and side-scatter
characteristics, were acquired uncompensated using a FACSCalibur (BD Bio-
sciences) ﬂow cytometer along with BD CompBeads to allow post hoc compen-
sation and data analysis with the FlowJo software program (Treestar, Ashland,
OR). The proportion of monocytes ingesting GBS was determined using a
threshold marker of 1.5% set on unstimulated monocytes. The degree of inges-
tion was determined from the mean ﬂuorescence intensity (MFI) of the positive
population or from the total population (phagocytic index). Cytokine-positive
cells were identiﬁed from a threshold marker of 1.5% for each ﬂuorophore set
using the matching isotype.
Statistical analysis. Data were summarized using medians, interquartile
ranges, and ranges or using means and their standard errors (SEM). Two group
comparisons of outcomes were performed using the Mann-Whitney test or Wil-
coxon signed rank test for paired observations as appropriate. Group analysis
was performed using two-way analysis of variance (ANOVA) with Bonferroni’s
adjustment for multiple comparisons. All analyses were conducted using the
Prism 5 for Mac software program (GraphPad, La Jolla, CA). All P values were
two sided and were considered signiﬁcant at 	0.05.
RESULTS
Impaired preterm cytokine responses to GBS. We compared
the cytokine responses (TNF-, IL-6, IFN-, IL-13, and IL-10)
of preterm, term, and adult MNC after stimulation with either
HKGBS or PHA. Two distinct stimulus-dependent patterns of
responses were observed. First, the levels of all cytokines in-
duced by PHA, except IL-13, were signiﬁcantly lower for both
the preterm and term infants in comparison to those for adult
cells, but responses did not differ between the neonatal groups
(Fig. 1 and 2). Responses to HKGBS were more complex. The
levels of TNF- and IL-6 were not signiﬁcantly different be-
tween term infants and adults but were signiﬁcantly lower for
the preterm infants than for both term infants and adults (Fig.
2). As with PHA, levels of IFN- and IL-10 were signiﬁcantly
and equivalently lower following HKGBS stimulation for both
preterm and term infants than for adults (Fig. 1).
Source and kinetics of PHA- and GBS-induced cytokines.
The distinct cytokine responses observed between preterm and
term infants to GBS and PHA suggested that these stimuli
might differentially activate speciﬁc MNC cell types. We there-
fore examined the kinetics of monocyte-, B cell- and T cell-
speciﬁc cytokine responses to both HKGBS and PHA (Fig. 3).
Adult MNC were used in order to deﬁne a normal “compe-
tent” response to GBS and because of the larger cell numbers
required. T cells were the major producers of TNF-, IL-6, and
IL-10 in response to PHA stimulation, with peak responses
between 24 and 48 h and with 20 to 30% of all T cells respond-
ing. In contrast, 	5% of all cell types produced IFN- in
response to PHA. The kinetics and cellular source of cytokine
responses to HKGBS varied with the type of cytokine.
HKGBS-induced IL-10 was detected from 24 h to 48 h in 	5%
of all cell types, whereas B cells were the major producers of
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produced exclusively by monocytes, with peak responses after
6 h and 
40% of monocytes producing TNF- but 	10%
producing IL-6. After 6 h, expression of both cytokines dimin-
ished rapidly. Dual staining conﬁrmed that HKGBS-induced
IL-6 and TNF- were coexpressed (data not shown).
Normal phagocytosis of GBS by preterm monocytes. To
determine if the lower levels of TNF- and IL-6 in response to
HKGBS for preterm infants might reﬂect an impaired capacity
of monocytes to phagocytose HKGBS, we assessed nonopsonic
and opsonic uptake of HKGBS. The preterm group was fur-
ther differentiated as either extremely (	30 weeks) or moder-
ately (31 to 33 weeks) preterm, to determine if there was a
GA-dependent phagocytic deﬁciency. FACS analysis of MNC
revealed that monocytes were the only cell phagocytosing
HKGBS, regardless of opsonization status (data not shown).
Phagocytosis of nonopsonized HKGBS by monocytes from all
groups was efﬁcient and equivalent, with at least 60% of the
monocyte population ingesting HKGBS on average (Fig. 4B).
Opsonization of HKGBS with complement increased mono-
cyte phagocytosis in all groups, signiﬁcantly so for the moder-
ate preterm and term groups, with 10 to 20% more monocytes
ingesting bacteria on average (Fig. 4B). There was no signiﬁ-
cant difference between the groups in the number of HKGBS
phagocytosed per monocyte (determined by MFI; data not
shown).
FIG. 1. Neonatal and adult MNC lymphocyte cytokine responses to PHA or GBS. CBMC or PBMC were incubated for 48 h with optimal doses
of heat-killed GBS (1  10
8 CFU/ml) or PHA. Data shown are box-whisker plots with outliers (Tukey); n  8 to 10 for preterm (26- to 33-week
GA), 43 for term (	37-week GA), and 37 for adult. *, P 	 0.05; **, P 	 0.005; ***, P 	 0.0005.
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investigate whether there was an intrinsic defect in preterm
monocyte cytokine production, we examined HKGBS uptake
and cytokine production on a per-cell basis. In all groups,
monocytes were the sole source of both TNF- and IL-6 (data
not shown) and all cytokine-positive monocytes were also pos-
itive for internalized HKGBS (Fig. 5A). Notably, not all mono-
cytes with internalized HKGBS secreted cytokine. Signiﬁcantly
fewer GBS-containing monocytes in the extreme preterm
group were also IL-6 positive than was the case for term in-
fants, and there was a trend toward fewer TNF--producing
cells as well (Fig. 5B and C). The TNF- and IL-6 responses of
CBMCs from moderately preterm infants did not differ signif-
icantly from those for term infants or adults, although there
was also a trend toward lower IL-6 production in this group.
Opsonization of HKGBS did not increase the proportion of
moderately preterm, term, or adult monocytes producing
TNF- but did signiﬁcantly increase the proportion producing
IL-6, 2- to 3-fold (Fig. 5B and C) (P 	 0.03 for all groups,
comparing nonopsonic to opsonic, using the Wilcoxon signed
rank test). Importantly, opsonization of HKGBS failed to
“normalize” cytokine production by monocytes from extreme
preterm infants to levels comparable to those of other groups,
with the signiﬁcantly fewer monocytes producing either TNF-
or IL-6 in comparison to term infants or adults. There were no
differences between the groups in the magnitude of the cyto-
kines response per monocyte (as determined by MFI of posi-
tive cells; data not shown).
Cord blood responses to live GBS are impaired in preterm
infants. We investigated whether the deﬁciency in preterm
infants’ monocytic cytokine production in response to GBS was
present in the most clinically relevant model: whole blood
challenged with live GBS. Term cord blood and adult periph-
eral blood were responsive to all doses of live GBS, producing
signiﬁcant levels of TNF- and IL-6 (Fig. 6A). However, the
level of IL-6 produced by term cord blood was signiﬁcantly
higher (2.5-fold) than that produced by adult peripheral
blood at all live GBS doses. TNF- production was higher in
adult blood at the lowest dose of live GBS (10
5/ml) but pla-
teaued thereafter, whereas production by term blood was dose
dependent (Fig. 6A). Preterm cord blood (	30 weeks) was less
responsive than adult and term blood, requiring a log higher
inoculum of live GBS to elicit detectable TNF- production.
Preterm infant TNF- and IL-6 levels were lower than those of
term infants, with differences reaching signiﬁcance at higher
GBS inocula (Fig. 6A). Preterm TNF- levels were less than
those from adult blood at all inocula, but IL-6 levels appeared
to be higher than those for adult blood at doses of 10
6/ml,
although this did not achieve signiﬁcance (Fig. 6A). The mono-
cyte-speciﬁc responses to live GBS, assessed by intracellular
cytokine staining, mirrored the cytokine secretion data (Fig.
6B). As with HKGBS (Fig. 5), the proportion of preterm
FIG. 2. Neonatal and adult MNC innate/inﬂammatory cytokine responses to PHA or GBS. CBMC or PBMC were incubated for 48 h with
optimal doses of heat-killed GBS (1  10
8 CFU/ml) or PHA. Data shown are box-whisker plots with outliers (Tukey); n  8 to 10 for preterm
(26- to 33-week GA), 43 for term (	37-week GA), and 37 for adult. *, P 	 0.05; **, P 	 0.005; ***, P 	 0.0005.
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GBS was signiﬁcantly lower than that in term infants. How-
ever, this effect was dose dependent, with the differences in
TNF- production signiﬁcant at live GBS doses of 10
6/ml,
whereas the signiﬁcant differences in IL-6 were observed only
at 10
7/ml. An examination of phagocytosis in whole blood
(assessed by pHrodo-labeled heat-killed GBS) showed no dif-
ference in the capacity of monocytes from preterm infants to
ingest HKGBS. Notably, preterm neutrophils showed signiﬁ-
cantly more uptake of HKGBS than adult neutrophils (P 	
0.05) but not term neutrophils (Fig. 6C). The addition of RbC
to whole-blood cultures did not alter phagocytic uptake by
either monocytes or neutrophils from any group.
DISCUSSION
Preterm infants are particularly susceptible to GBS infec-
tion, with worse outcomes, but the underlying mechanisms
remain unclear. We investigated the cellular and molecular
competence of monocyte and lymphocyte responses to live and
heat-killed GBS in preterm and term infants and adults. Our
data indicate the following: (i) innate immune responses to
GBS are driven by monocytes and are deﬁcient only in preterm
infants, particularly those with a GA of 	30 weeks; (ii) the
deﬁcient monocyte cytokine response of preterm infants to
GBS is present in whole blood but is not limited by the degree
of opsonic uptake of the bacteria; and (iii) newborn lympho-
cyte responses to GBS may be impaired in comparison to adult
responses, regardless of GA. Our ﬁndings suggest a major
impairment in immune responses to GBS in preterm infants,
which is likely to contribute to their increased susceptibility.
Deﬁcient preterm monocytic responses to GBS. The rapid
onset of GBS sepsis in newborns suggests that the early control
of GBS infection requires adequate engagement of host innate
immune defenses (16). Our kinetic studies using adult cells
demonstrated that innate cytokine responses were activated
FIG. 3. Cell-speciﬁc intracellular cytokine production by adult
MNC in response to GBS or PHA. PBMC were stimulated for 0, 6, 24,
and 48 h with either PHA or HKGBS (1  10
8 CFU/ml), brefeldin A
was added for the last4ho fstimulation at each time point, and cells
were stained for cytokine and cell lineage markers. Data shown are
means  SEM (n  4 donors).
FIG. 4. Nonopsonic and opsonic phagocytosis of GBS by neonatal
and adult monocytes. CBMC or PBMC were incubated for 1 h with
pHrodo dye-labeled HKGBS (1  10
8 CFU/ml) with our without RbC.
(A) Left panel, representative forward-scatter (FSC) versus side-scat-
ter (SSC) FACS plot showing inclusion gate for monocytes; right
panel, representative histograms showing pHrodo-speciﬁc ﬂuores-
cence in monocytes without bacteria or with GBS plus or minus RbC.
(B) Percentage of monocytes positive for phagocytosed GBS (means 
SEM). n  11 for the 	30-week group, 15 for the 31- to 33-week and
term groups, and 18 for adults. *, P 	 0.0151; **, P 	 0.0084; Wil-
coxon signed rank test comparing phagocytosis of GBS with and with-
out RbC.
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inﬂammatory cytokine production. Notably, production of
these cytokines by CBMC from term infants was not impaired
relative to that for adults, and whole-blood responses exceeded
adult responses. This suggests that the blood monocyte com-
partment of healthy, term infants is functionally competent in
recognizing and responding to GBS. Several studies have dem-
onstrated equivalent or greater inﬂammatory production by
term MNC (in CBMC or whole blood) after GBS stimulation
(27, 47), with cytokine production predominantly monocyte
derived (35, 40, 44). Our data, derived using live bacteria over
a range of inocula, are therefore consistent with GBS exposure
resulting in an overt inﬂammatory response in the newborn
(16).
In contrast to term infant responses, TNF and IL-6 re-
sponses of preterm infants with a GA of 	30 weeks were
signiﬁcantly impaired due to a reduced proportion of cytokine-
producing monocytes. Similarly, preterm monocyte responses
in whole cord blood stimulated with live GBS were consistently
weaker than those of term infants. However, IL-6 production
remained greater than adult responses at the highest inocula,
consistent with the inﬂammatory nature of GBS sepsis even in
the preterm infant (16). Thus, the trend toward equivalent or
higher cytokine responses in the very preterm infants in com-
parison to adult responses when high doses of inocula were
used could explain how an early failure in recognition/control
of GBS still leads to inﬂammatory sequelae in this vulnerable
population.
The reduced responsiveness observed in preterm CBMC
inversely correlated with GA, consistent with data on preterm
responses to LPS and a range of live bacteria, including GBS
(47). This study did not examine the cellular source of cyto-
kine, but the authors speculated that the impaired response
resulted from inherently defective monocyte function, as we
have now demonstrated. Similar GA-dependent responses are
reported following LPS stimulation (6), with infants with a GA
of 	32 weeks having a lower proportion of IL-6-producing
monocytes (35). A recent study examining intracellular cyto-
kine responses to GBS and other bacterial stimuli in preterm
infants did not ﬁnd a signiﬁcant impairment in IL-6, -8, -10,
and -12 production in comparison to that of term infants or
adults, although responses were monocyte driven (40). How-
ever, the levels of secreted cytokines produced by each group
were not measured, and the study did not distinguish between
extreme and moderate preterm infants. Additionally, differ-
ences in the stimulation protocols used (prolonged brefeldin A
exposure versus only a 4-h exposure in our study) complicates
any comparison.
Normal opsonic uptake of HKGBS by preterm infants. The
relative impairment in inﬂammatory cytokine monocyte re-
sponses of very preterm infants did not result from a reduced
capacity to bind and phagocytose nonopsonized or opsonized
HKGBS, despite the requirement for bacterial internalization
to induce cytokine. There is limited information on the effects
of prematurity on monocyte phagocytosis, but studies on pre-
term neutrophils and preterm rabbit alveolar macrophages
report impaired bacterial uptake (13, 20). The uptake of pre-
opsonized (pooled adult sera) Escherichia coli by peripheral
blood neutrophils from stressed and well-preterm infants (GA
of 	32 weeks) was found to be modestly impaired in compar-
ison to that of adults and healthy term infants but not related
directly to expression levels of complement or immunoglobulin
receptors (8). Similarly, Bektas et. al. (4) found that neutro-
phils from preterm infants (GA, 28 to 36 weeks) were less able
to phagocytose pooled-serum opsonized Candida albicans than
those from adults (4). However, they also noted that the levels
of opsonic S. aureus uptake and induction of O2
 were com-
parable between the groups, suggesting that any impairment in
phagocytosis may be pathogen speciﬁc. In contrast, Fujiwara
et. al. (10) found that peripheral blood neutrophil uptake of S.
FIG. 5. Monocyte-speciﬁc TNF- and IL-6 production with respect
to GBS uptake. CBMC and PBMC were exposed to 1  10
8 CFU/ml
pHrodo-HKGBS (plus or minus RbC) for 1 h and then washed and
incubated for a further4hi nt h epresence of brefeldin A before
staining for intracellular cytokine. (A) Left panel, representative for-
ward-scatter versus side-scatter FACS plot showing inclusion gate for
monocytes; right panel, representative FACS plot showing monocyte-
speciﬁc TNF- production in association with ingestion of pHrodo-
GBS. (B and C) Percentage of HKGBS-positive monocytes producing
TNF- or IL-6 (means  SEM). n  10 for the 	-30-week group, 13
for the 31- to 33-week and term groups, and 14 for adults. P values
(Mann-Whitney test) are as displayed.
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adults but could be increased by opsonization with adult
plasma (10).
Impaired opsonic uptake of GBS in whole preterm blood
might result from low levels of maternal GBS-speciﬁc antibody
(15, 25) or deﬁcient complement levels and activation (24).
However, we found comparable levels of monocytic phagocy-
tosis and apparently higher levels of neutrophil phagocytosis in
fresh cord blood from extreme-preterm infants. Bialek and
Bartmann (4a) examined phagocytosis of preopsonized GBS
by neutrophils in the peripheral blood of preterm infants with
aG Ao f	32 weeks and adults and found that phagocytosis
(measured as a percentage of phagocytosing cells) was equiv-
alent if pooled adult serum was used as opsonin but deﬁcient
in preterm infants if a pool of preterm serum was used. The
opsonic effects seen with the adult and preterm serums used
FIG. 6. Fresh cord-blood responses to live GBS. (A and B) Fresh cord/venous blood IL-6 and TNF responses to live GBS determined by
Bioplex assay of culture supernatants or by intracellular cytokine staining (of monocytes), respectively. Data shown are means  SEM; n  6 for
preterm infants (	30-week GA), 8 for term infants, and 9 for adults. *,† ,‡ ,P 	 0.05; **, ††, ‡‡, P 	 0.01; ***,†††, ‡‡‡, P 	 0.001, comparing
responses between preterm and term infants (*), preterm infants and adults (†), or term infants and adults (‡) using two-way ANOVA with
Bonferroni’s adjustment for multiple comparisons. (C) Phagocytosis of HKGBS by neutrophils or monocytes in freshly isolated cord blood from
preterm infants (	30-week GA; n  4) and term infants (n  5) or venous blood from adults (n  7), as determined by ﬂow cytometry using
pHrodo-labeled HKGBS (5  10
7 CFU/ml). Data shown are means  SEM. †, P 	 0.05, comparing uptake by preterm cells to that by adults using
two-way ANOVA with Bonferroni’s adjustment for multiple comparisons.
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GBS-speciﬁc antibodies, implicating complement as a major
limiting factor. The fact that we could detect no defect in GBS
uptake in preterm cord blood when it was added in unop-
sonized form and that addition of rabbit complement did not
increase GBS uptake in any group suggests that there are
sufﬁcient opsonins available, at least in cord blood, to mediate
initial GBS ingestion by the preterm infant. A detailed exam-
ination of preterm infant neutrophil and monocyte phagocytic
capacity (for GBS and other pathogens) in cord and peripheral
blood would be informative.
Overall, our ﬁndings, in keeping with published data on GBS
and/or other bacterium-derived stimuli (6, 47), indicate that
monocytes from preterm infants have an intrinsic, GA-related
deﬁciency in their ability to recognize and respond to GBS.
This may reﬂect fundamental impairment in the innate recog-
nition systems broadly involved in host defense, such as the
Toll-like receptors (TLR) or Nod-like receptors (NLR) (16).
TLR and NLR function in preterm infants is poorly under-
stood, although recent data suggest this group has deﬁcient
responses to TLR2 and TLR4 agonists, possibly due to re-
duced MyD88 expression and p38 mitogen-activated protein
kinase (MAPK) induction (34). Consistent with our ﬁndings,
the greatest degree of impairment was seen in those born at a
	30-week GA.
Our data would also suggest that this intrinsic defect is not
common to all monocytes but instead resides in a speciﬁc
subset that is capable of phagocytosis but not response to
bacterial stimuli. Human monocytes consist of at least two
functionally distinct subsets (CD14
dim/CD16
 and CD14
hi/
CD16
) which differ in TLR expression and cytokine produc-
tion (5, 37), although there is likely to be more complex func-
tional heterogeneity (7). We did not ﬁnd differences in the
proportions of CD16
 and CD16
 monocytes in unstimulated
cord blood from preterm and term infants (data not shown).
Further investigation of the development of the newborn
monocyte system and the response to neonatal pathogens and
bacterial ligands is warranted.
Impaired newborn lymphocytic responses to HKGBS. There
is a general consensus that newborn lymphocyte/adaptive re-
sponses are impaired or immature compared to those of adults
(3). A relative reduction in Th1 responses (IFN-) with con-
comitant Th2 polarization in the newborn is often emphasized
(1, 2, 26), although more recent studies also suggest an impair-
ment in newborn lymphocyte-derived regulatory cytokines
(such as IL-10) and regulatory T-cell function as well (14, 36).
We did ﬁnd that IFN- and IL-10 production was lower in
newborn CBMC than in adult PBMC following HKGBS and
PHA stimulation, consistent with previous data (19, 45, 46).
Our adult kinetic studies conﬁrmed that both cytokines were
produced in large part by T and B cells (especially after PHA
stimulation), and we were able to detect lymphocytic prolifer-
ation in response to GBS that was impaired in CBMC. Re-
duced lymphocyte IFN- may reﬂect impaired IL-12 and IL-18
production induced by GBS (22) and, together with reduced
IL-10, might suggest a bias toward Th2 responses to GBS in
the newborn. IL-13 was indeed induced by GBS in our system,
but the levels were relatively low and did not vary between
newborns and adults. PHA-induced IL-13 responses were sim-
ilar between groups, consistent with studies that demonstrate
no inherent Th2 bias in newborn lymphocyte responses follow-
ing mitogen stimulation (14). Our data would therefore sug-
gest a general impairment in lymphocyte responses to GBS at
birth, consistent with its role as a major pathogen in the ﬁrst
few days and weeks of life.
Conclusion. We have demonstrated that monocyte and lym-
phocyte cytokine responses of the preterm infant are function-
ally impaired, with the degree of monocyte impairment in-
versely correlating with GA. Failure to mount a coordinated
and timely immune response to GBS in preterm infants is
likely to contribute to increased susceptibility and worse out-
comes. Future strategies that augment innate function and/or
adaptive immunity (including regulatory cytokine induction)
may reduce the burden of GBS disease, particularly in preterm
infants and other high-risk groups.
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